Get started
Author

Emilie Mirey

Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain
2012 · Mélanie Pichery, Emilie Mirey, et al. · The Journal of Immunology · 494
Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
2014 · Emma Lefrançais, Anais Duval, et al. · Proceedings of the National Academy of Sciences · 408
TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation
2024 · Pauline Schmitt, Anais Duval, et al. · The Journal of Experimental Medicine · 54
PDF
Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models
2022 · Lucas Blanchard, Estefania Vina, et al. · STAR Protocols · 5
PDF
Abstract 1731: EXS21546, a non-CNS penetrant A2AR-selective antagonist for anti-cancer immunotherapy
2021 · Andrew Payne, Pierre Fons, et al. · Cancer Research · 5
Isolation and Culture of Mouse Lung ILC2s
2018 · Pauline Schmitt, Anaïs Duval, et al. · BIO-PROTOCOL · 4
Abstract 519: EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug development
2019 · Pierre Fons, Andy Bell, et al. · Immunology · 1
Feasibility and Immunological Impact of Reusing Wild-Type C57BL/6 Mice in Systemic and Cutaneous Anaphylaxis Models 2309549
2026 · Emilie Mirey, Clement Costard, et al. · The Journal of Immunology
PDF
From Mouse to Clinic: Non-Invasive Swab-Based Profiling of Inflammatory and Barrier Markers in Atopic Dermatitis 2258968
2026 · Frederic Machet, Ludovic Bellec, et al. · The Journal of Immunology
PDF
Discovery of potent, selective and insurmountable MRGPRX2 antagonists for mast cell-driven disorders 2308475
2026 · Yves Millet, Josh Close, et al. · The Journal of Immunology
Abstract 519: EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug development
2019 · Pierre Fons, Andy Bell, et al. · Cancer Research
L' interleukine-33, un nouvel acteur de la réponse anti-tumorale dans un modèle murin de cancer du côlon
2014 · Emilie Mirey · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
PDF
Works count: 12
Citation count: 971
H-index: 5
I10-index: 3
Year
Topic
Type